Amgen stock heads into the open after a 1.55% pullback
Published on 09/08/2026 at 07:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock closed at USD 437.23 on the Nasdaq on September 4, 2026, down 1.55 percent from the prior close according to market data.Investing.com That finish put the shares between their recent 52-week low of USD 269.77 and high of USD 447.03, leaving some room below the top of the range.Investing.com Today, a newly raised Wells Fargo price target for the company is set to shape sentiment ahead of the opening bell.Gelonghui Finance
September 4, 2026 in numbers
Amgen Inc. (ISIN US0311621009, Nasdaq: AMGN) ended the last completed session at USD 437.23, with intraday trading spanning a low of USD 435.00 and a high of USD 441.85 on September 4, 2026.Investing.com The move represented a 1.55% decline on the day, as volume reached about 1,660,000 shares, broadly in line with the stock's recent average activity.Investing.com At this closing level, the shares stood roughly USD 9.80 below the documented 52-week high of USD 447.03, underscoring a moderate gap to the peak quoted over the past year.Investing.com In the context of that wider range from USD 269.77 to USD 447.03, the stock remained closer to the upper end than to the low, reflecting the strong multi-month advance that preceded the latest pullback.Investing.com
After the regular session ended, quoted after-hours levels pointed to a separate indication of USD 415.00 on September 4, 2026, marked as an after-hours move rather than part of the official close.Investing.com This post-close indication implied an additional downside shift compared with the regular-session finish, though it did not alter the formal closing price used for performance measures.Investing.com Against the broader backdrop, the stock's recent climb from the 52-week low of USD 269.77 to levels above USD 430 has been substantial in absolute terms, even with the 1.55% decline in the last session.Investing.com That combination of elevated price versus the yearly trough and short-term volatility around the high sets the frame for trading into today's session.
Today’s drivers and events
Today, Wells Fargo is cited as having raised its price target for Amgen from USD 400 to USD 435 while keeping a neutral rating, a development that adds a new reference point for investors as they assess the stock ahead of the open.Gelonghui Finance The revised target sits slightly below the latest regular-session close of USD 437.23, highlighting a cautious stance despite the stock's move near its 52-week high.Investing.comGelonghui Finance This analyst adjustment may influence expectations for Amgen's risk-reward profile in the near term, particularly for market participants tracking sell-side views alongside recent price action.Gelonghui Finance In the broader market environment, investors will also weigh sector trends and index performance from the prior sessions when positioning around Amgen today, even though no additional company-specific events have been flagged for the immediate trading window in the available calendars.
